State of the Evidence: The Connection Between Breast Cancer and the Environment

References

• Lux MP, Fasching PA, Beckmann MW. Hereditary breast and ovarian cancer: review and future perspectives. J Mol Med. 2006; 84: 16–28.
   PubMed Web of Science ®Google Scholar
• Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004; 6: 213–18.
   PubMed Web of Science ®Google Scholar
• Michels KB, Mohllajee AP, Roset-Bahmanyar ER., et al Diet and breast cancer. Cancer 2007; 109 (512): 2712–49
   PubMedGoogle Scholar
• Zheng SM, Lee I-M, Manson JE., et al Alcohol consumption and breast cancer risk in the Women's Health Study. Am J Epi-demiol. 2007; 165: 667–76.
   PubMed Web of Science ®Google Scholar
• Visvanathan K, Crum RM, Strickland PT., et al Alcohol dehy-drogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcohol: Clin Exp Res. 2007; 31: 467–76.
   PubMed Web of Science ®Google Scholar
• Monninkhof EM, Elias SG, Vlems FA., et al Physical activity and breast cancer: a systematic review. Epidemiology. 2007; 18: 137–57.
   PubMed Web of Science ®Google Scholar
• Kruk J, Aboul-Enein I-W Environmental exposure, and other behavioral risk factors in breast cancer. Curr Cancer Ther Rev. 2006; 2: 3–21.
   Google Scholar
• Cutler SJ, Connelly, RR. Mammary cancer trends. Cancer. 1969; 23: 767–71.
   PubMed Web of Science ®Google Scholar
• Jatoi I, Anderson WF, Rao SR, Devesa SS. Breast cancer trends among black and white women in the United States. J Clin Oncol. 2005; 23: 7836–41.
   PubMed Web of Science ®Google Scholar
• Ries LAG, Melbert D, Krapcho M, et al. (eds). SEER Cancer Sta-tistics Review, 1975-2004. Bethesda (MD): National Cancer Insti-tute; [Internet]. 2006 Nov. Available from: www.seer.cancer. gov/csr/1975_2004
   Google Scholar
• Jemal A, Siegel E, Ward E., et al Cancer statistics: 2006. CA: Cancer J Clin. 2006; 56: 106–30.
   PubMed Web of Science ®Google Scholar
• Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer sta-tistics, trends and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Result (SEER) Program. Oncologist. 2007; 12: 20–37.
   PubMed Web of Science ®Google Scholar
• Ravdin PM, Cronin KA, Howlader N., et al The decrease in inci-dence in breast cancer incidence in 2003 in the United States. N Engl J Med. 2007; 356: 1670-74.
   Google Scholar
• Glass AG, Lacey JV, Carreon JD, Hoover RN. Breast cancer inci-dence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007; 99: 1152-61.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Decline in breast cancer incidence United States, 1999-2003. Morbidity and Mortality Weekly Report. 2007; 56: 549–53.
   PubMedGoogle Scholar
• Robbins AS Clarke CA. Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol. 2007; 25: 3437–9.
   Google Scholar
• Colditz GA. Decline in breast cancer inidence due to removal of promoter: combination estrogen plus progestin. Breast Cancer Res. 2007; 9: 108.
   PubMedGoogle Scholar
• In this report we have chosen to use the terms for various racial and ethnic groups that have been used by the authors of partic-ular papers we are citing. We recognize the complexity, and per-haps inappropriateness, of using simple names to categorize richly diverse groups of people who are clustered together somewhat arbitrarily because of their biological, social or cul-tural histories. Yet we also believe it is important to cite and dis-cuss the growing scientific literature demonstrating disparities in exposures and responses to exposures across different racially and ethnically designated groups.
   Google Scholar
• Smigal C, Jemal A, Ward E., et al Trends in breast cancer by race and ethnicity: update 2006. CA: Cancer J Clin. 2006; 56: 168–83.
   PubMed Web of Science ®Google Scholar
• Bowen RL, Stebbing J, Jones U. A review of the ethnic differ-ences in breast cancer. Pharmacogenomics. 2006; 7: 935–42.21.
   PubMed Web of Science ®Google Scholar
• Jones BA, Kasl SV, Howe CL., et al African American/White dif-ferences in breast cancer carcinoma. Cancer. 2004; 101: 1293–1301.
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. Health, United States, 2006: chartbook on trends in the health of Americans [Inter-net]. 2006; Available from http:www.cdc.gov/nchs/data/hus/hus06.pdf
   Google Scholar
• Parkin DM, Fernandez, LM. Use of statistics to assess the global burden of breast cancer. Breast J. 2006;12(Suppl 1):S70–S80.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: Cancer J Clin. 2005; 55: 74–108.
   PubMed Web of Science ®Google Scholar
• Boffetta P, Parkin DM. Cancer in developing countries. CA: Cancer J Clin. 1994; 44: 81–90.
   PubMed Web of Science ®Google Scholar
• Althuis MD, Dozier JM, Anderson WF., et al Global trends in breast cancer incidence and mortality 1973-1997. Int J Epi-demiol. 2005; 34: 405–12.
   PubMed Web of Science ®Google Scholar
• Ziegler RG, Hoover RN, Pike MC., et al Migration patterns and breast cancer risk in Asian American women. J Natl Cancer Inst. 1993;85(22) :1819–27.
   PubMed Web of Science ®Google Scholar
• Stanford JL, Herrinton LJ, Schwartz SM, Weiss NS. Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology. 1995; 6: 181–3.
   PubMed Web of Science ®Google Scholar
• John EM, Phipps Al, Koo J. Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prey. 2005; 14: 2905–13.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Li X. Cancer risks in second-generation immi-grants to Sweden. Int J Cancer. 2002; 99: 229–37.
   PubMed Web of Science ®Google Scholar
• Andreeva VA, Unger JB, Pentz MA. Breast caner among immi-grants; A systematic review and new research directions. J Immi-grant Minority Health. 2007; 9: 307–322.
   PubMedGoogle Scholar
• Birnbaum LS, Fenton SE. Cancer and developmental exposure to endocrine disruptors. Environ Health Persp. 2003; 111: 389–94.
   PubMed Web of Science ®Google Scholar
• Sasco A. Epidemiology of breast cancer: An environmental dis-ease? APMIS. 2001; 109: 321–32.
   Google Scholar
• King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited muta-tions in BRCA1 and BRCA2. Science. 2003; 302: 643–46.
   Google Scholar
• Simchoni S, Friedman E, Kaufman B., et al Familial clustering of site-specific cancer risks associated with BRCAland BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci. 2006; 103: 3770-74.
   Google Scholar
• Kroiss R, Winkler V, Bikas D., et al Younger birth cohort corre-lates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers. Hum Mut. 2005; 26: 583–9.
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Niels V, Pia K. Environmental and heritable fac-tors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark and Finland. N Engl J Med. 2000; 343 (2): 78–85.
   PubMed Web of Science ®Google Scholar
• Baker SG, Lichtenstein P, Kaprio J, Holm N. Genetic suscepti-bility to prostate, breast, and colorectal cancer among Nordic twins. Biometrics. 2005; 61: 55–63.
   PubMed Web of Science ®Google Scholar
• Czene K, Lichtenberg P, Hemminki K. Environmental and her-itable causes of cancer among 9.6 million individuals in the Swedish family cancer database. Int J Cancer. 2002;99;260–66.
   PubMed Web of Science ®Google Scholar
• Boehm JS, ZhaoJ J, Yao J., et al Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell. 2007; 129: 1065–79.
   PubMed Web of Science ®Google Scholar
• Easton DF, Pooley KA, Dunning AM., et al Genome-wide sus-ceptibility study identifies novel breast cancer susceptibility loci. Nature 2007; 447: 1087–1093.
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Kraft P, Jacobs KB., et al A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007; 39 (7): 870–4.
   PubMed Web of Science ®Google Scholar
• Zuo T, Wang L, Morrison C., et al FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the 1-IER-2/ErbB2 oncogene. Cell. 2007;29; 129 (7): 1275-86.
   Google Scholar
• American Cancer Society. Cancer facts and figures 2007. Atlanta, GA: American Cancer Society, Inc.
   Google Scholar
• Newman LA. Breast cancer in African American women. Oncol-ogist. 2005; 10: 1–14.
   PubMed Web of Science ®Google Scholar
• Carey LA, Perou CM, Livasy CA., et al Race, breast cancer sub-types, and survival in the Carolina Breast Cancer Study. J Am Med Assoc. 2006; 295: 2492–2502.
   PubMed Web of Science ®Google Scholar
• Swanson GM, Haslam SZ, Azzouz E Breast cancer among young African American women. Cancer Suppl. 2003; 97: 273–79.
   PubMedGoogle Scholar
• Hance KW, Anderson WF, Devesa SS., et al Trends in inflamma-tory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute. J Natl Cancer Inst. 2005; 97: 966–75.
   PubMed Web of Science ®Google Scholar
• Palmer JB, Wise LA, Horton NJ., et al Dual effect of parity on breast cancer risk in African American women. J Natl Cancer Inst. 2003; 95: 478–83.
   PubMed Web of Science ®Google Scholar
• Jernstrom H, Chu W, Vesprini D., et al Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab. 2001; 72: 144–54.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Third National Report on Human Exposure to Environmental Chemicals. Atlanta (GA): CDC, 2005.
   Google Scholar
• Bauer KR, Brown M, Cress RD., et al Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer. 2007; 109: 1721-28.
   Google Scholar
• Mills PK, Yang R. Breast cancer risk in Hispanic agricultural workers in California. Int J Occup Environ Health. 2005; 11: 123–31.
   PubMed Web of Science ®Google Scholar
• Li R, Gilliland FD, Baumgartner K, Samet J. Hormone replace-ment therapy and breast carcinoma risk in Hispanic and non-Hispanic women. Cancer. 2002; 95: 960–68.
   PubMed Web of Science ®Google Scholar
• Ely B, Wilson JL, Jackson F, Jackson BA. African-American mito-chondrial DNAs often match mtDNAs found in multiple African ethnic groups. BMC Biol. 2006; 4: 34.
   PubMed Web of Science ®Google Scholar
• Paltoo DN, Chu KC. Patterns in cancer incidence among Amer-ican Indians/Alaska Natives, United States, 1992-1999. Pub Health Rep. 2004; 119: 443–51.
   PubMed Web of Science ®Google Scholar
• Deapen D, Liu L, Perkins C., et al Rapidly rising breast cancer incidence rates among Asian American women. Int J Cancer. 2002; 99: 747–50.
   PubMed Web of Science ®Google Scholar
• Environmental Protection Agency, Office of Pollution Preven-tion and Toxics. Overview: Office of Pollution Prevention and Toxics Programs [Internet]. 2007 Oct 8. Available from: www.epa.gov/oppt/pubs/opptioic2.pdf, October 8, 2007.
   Google Scholar
• Bennett M, Davis BJ. The identification of mammary carcino-gens in rodent bioassays. Environ Mol Mut. 2002; 39 (2–3): 150–7.
   Google Scholar
• Brody JG, Moysich KB, Humblet O. et al. Environmental pollu-tants and breast cancer: epidemiologic studies. Cancer. 2007;109(Suppl 12):2667–711.
   PubMed Web of Science ®Google Scholar
• Rudel RA, Attfield KA, Schifano JN, Brody JG. Chemicals caus-ing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer. 2007;109(Suppl 12):2635–66.
   PubMed Web of Science ®Google Scholar
• Rudel RA, Camann DE, Spengler JD., et al Phthalates, alkylphe-nols, pesticides, polybrominated diphenyl ethers, and other endocrine-disrupting compounds in air and dust. Environ Sci Technol. 2003; 37: 4543–53.
   PubMed Web of Science ®Google Scholar
• Siddiqui MK, Anand M, Mehrotra PK., et al Biomonitoring of organochlorines in women with benign and malignant breast disease. Environ Res. 2004; 98: 250–7.
   Web of Science ®Google Scholar
• Nickerson K. Environmental contaminants in breast milk. J Mid-wifery Women's Health. 2006; 51: 26–34.
   PubMed Web of Science ®Google Scholar
• Dunnick JK, Elwell MR, Huff J, Barrett JC. Chemically induced mammary gland cancer in the National Toxicology Program's carcinogenesis bioassay. Carcinogenesis. 1995; 16: 173–9.
   PubMed Web of Science ®Google Scholar
• Wolff MS, Teitelbaum SL, Windham G., et al Pilot study of uri-nary biomarkers of phytoestrogens, phthalates, and phenols, in girls. Environ Health Persp. 2007; 115: 116–21.
   PubMed Web of Science ®Google Scholar
• Shen H, Main KM, Virtanen HE., et al From mother to child: Investigation of prenatal and postnatal exposure to persistent bioaccumulating toxicants using breast milk and placenta bio-monitoring. Chemosphere. 2007; 67: S236–S262.
   Google Scholar
• Chen JW, Wang SL, Yu HY., et al Body burden of dioxins and dioxin-like polychlorinated biphenyls in pregnant women resid-ing in a contaminated area. Chemosphere. 2006; 65: 1667–77.
   PubMed Web of Science ®Google Scholar
• Anderson HA, Wolff MS. Environmental contaminants in human milk. J Expo Anal Environ Epidemiol. 2000;10(11 Suppl.):755-60.
   Google Scholar
• Van der Ven K, Van der Ven H, Thibold A., et al Chlorinated hydrocarbon content of fetal and maternal body tissues and fluids in full term pregnant women: a comparison of Germany and Tanzania. Hum Reprod. 1992;7(Suppl. 1):95-100.
   Google Scholar
• Carpenter DO, Arcaro KF, Bush B., et al Human health and chemical mixtures: An overview. Environ Health Persp. 1998;106(Suppl 6):1263–70.
   PubMed Web of Science ®Google Scholar
• Kortenkamp A. Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective. Int J Androl. 2006; 29: 193–8.
   PubMedGoogle Scholar
• Koppe JG, Bartonova A, Bolte G., et al Exposure to multiple environmental agents and their effect. Acta Ped. 2006;95 (Suppl 453) :106–13.
   Google Scholar
• Ramamoorthy K, Wang F, Chen IC., et al Potency of combined estrogenic pesticides. Science. 1997; 275: 405–6.
   PubMed Web of Science ®Google Scholar
• Arnold SF, Klotz DM, Collins BM et al. Synergistic activation of estrogen receptor with combinations of environmental chemi-cals. Science. 1996; 272: 1489–92.
   Google Scholar
• Xie L, Thrippleton K, Irwin MA., et al Evaluation of estrogenic activities of aquatic herbicides and surfactants using a rainbow trout vitellogenin assay. Toxicol Sci. 2005; 87: 391–8.
   PubMed Web of Science ®Google Scholar
• Payne J, Rajapakse N, Wilkins M., et al Prediction and assess-ment of the effects of mixtures of four xenoestrogens. Environ Health Perspect 2000; 108: 983–7.
   PubMed Web of Science ®Google Scholar
• Rajapakse N, Silva E, Kortenkamp A. Combining xenoestrogens at levels below individual no-observed-effect concentrations dra-matically enhances steroid hormone action. Environ Health Persp. 2002; 110: 917–21.
   PubMed Web of Science ®Google Scholar
• Rajapakse N, Ong D, Kortenkamp A. Defining the impact of weakly estrogenic chemicals on the action of steroidal chemi-cals. Toxicol Sci. 2001; 60: 296–304.
   PubMed Web of Science ®Google Scholar
• Russo J, Russo I. The role of estrogen in breast cancer. In: Mol-ecular basis of breast cancer. Berlin: Springer-Verlag; 2004. Chapter 4: p 89-136.
   Google Scholar
• Foster WG, Younglai EV, Boutross-Tadross O. et al. Mammary gland morphology in Sprague-Dawley rats following treatment with an organochlorine mixture in utero and neonatal genis-tein. Toxicol Sci. 2004; 77: 91–100.
   PubMed Web of Science ®Google Scholar
• Imaoka T, Nishimura M, Teramoto A., et al Cooperative induc-tion of rat mammary cancer by radiation and 1-methy1-1-nitro-surea via the oncogenic pathways involving c-Myc activation and H-ras mutation. Int J Cancer. 2005; 115: 187–93.
   PubMed Web of Science ®Google Scholar
• Millikan R, DeVoto E, Duell EJ., et al Dichloro-diphenyl-dichloroethene, polychlorinated biphenyls and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prey. 2000; 9: 1233–40.
   PubMed Web of Science ®Google Scholar
• Laden F, Ishibe N, Hankinson SE., et al Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prey. 2002; 11: 1560–5.
   PubMed Web of Science ®Google Scholar
• Olivier M, Hainaut P. TP53 mutation patterns in breast can-cers: searching for clues of environmental carcinogenesis. Sem Cancer Biol. 2001; 11: 353–60.
   PubMed Web of Science ®Google Scholar
• Calabrese EJ. Hormesis: from marginalization to mainstream: a case for hormesis as the default dose-response model in risk assessment. Toxicol App Pharmacol. 2004; 197: 125–36.
   PubMed Web of Science ®Google Scholar
• Fenton SE. Endocrine-disrupting compounds and mammary gland development: early exposure and later life conse-quences. Endocrinology. 2006;147 (Suppl):S18-S24.
   Google Scholar
• Russo J, Hu YF, Silva ID, Russo IH. Cancer risk related to mam-mary gland structure and development. Microsc Res Tech. 2001; 52: 204–23.
   PubMed Web of Science ®Google Scholar
• Guisti RM, Iwamoto K, Hatch EE. Diethystilbestrol revisited: a review of the long-term health effects. Ann Intern Med. 1995; 122: 778–88.
   PubMed Web of Science ®Google Scholar
• Li S, Hursting SD, Davis BJ., et al Environmental exposure, DNA methylation, and gene regulation: lessons from diethyl-stilbestrol-induced cancers. Ann NYAcad Sci. 2003; 983: 161–9.
   PubMed Web of Science ®Google Scholar
• Colton T, Greenberg ER, Noller K., et al Breast cancer in moth-ers prescribed diethylstilbestrol in pregnancy: further follow-up. J Am Med Assoc. 1993; 269: 2096–2100.
   PubMed Web of Science ®Google Scholar
• Titus-Ernstoff L, Hatch EE, Hoover RN., et al Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Brit J Cancer. 2001. 84: 126–133.
   PubMed Web of Science ®Google Scholar
• Troisi R, Hatch EE, Titus-Ernstoff L., et al Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer. 2007; 121: 356–60.
   PubMed Web of Science ®Google Scholar
• Hilakivi-Clarke L, de Assis S. Fetal origins of breast cancer. Trends Endocrinol Metab. 2006; 17: 340–8.
   PubMed Web of Science ®Google Scholar
• Roseboom T, de Rooij S, Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum Dev. 2006; 82: 485–91.
   PubMed Web of Science ®Google Scholar
• Santodonato J. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: relationship to carcinogenicity. Chemosphere. 1997; 34: 835–48.
   PubMed Web of Science ®Google Scholar
• Bonner MR, Han D, Nie J., et al Breast cancer risk and expo-sure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epi-demiol Biomarkers Prey. 2005; 14: 53–60.
   PubMed Web of Science ®Google Scholar
• Calafat AM, Kuklenyik Z, Reidy JA., et al Urinary concentra-tions of bisphenol A and 4-nonyphenol in a human reference population. Environ Health Persp. 2005; 113: 391–5.
   PubMed Web of Science ®Google Scholar
• Munoz-de-Toro M, Markey C, Perinaaz RW., et al Perinatal exposure to bisphenol A alters peripubertal mammary gland development in mice. Endocrinology. 2005; 146: 4138–47.
   PubMed Web of Science ®Google Scholar
• Vandenberg LN, Mafflni MV, Wadia PR., et al Exposure to envi-ronmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology. 2007; 148: 116–27.
   PubMed Web of Science ®Google Scholar
• Markey CM, Luque EH, Munoz-de-Toro MM., et al In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod. 2001; 65: 1215–23.
   PubMed Web of Science ®Google Scholar
• Murray TJ, Mafflni MV, Ucci AA., et al Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol. 2007; 23: 383–90.
   PubMed Web of Science ®Google Scholar
• Brown NM, Manzolillo PA, Zhang J-H., et al Prenatal TCCD and predisposition to mammary cancer in the rat. Carcinogen-esis. 1998; 1: 1623–9.
   Google Scholar
• Fenton SE, Hamm JT, Birnbaum LA, Youngblood GL. Persis-tent abnormalities in the rat mammary gland following gesta-tional and lactational exposure to 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD). Toxicol Sci. 2002; 67: 63–74.
   PubMed Web of Science ®Google Scholar
• Jenkins S, Rowell C, Wang J, Lamartiniere. Prenatal TCDD exposure predisposes for mammary cancer in rats. Reprod Toxicol. 2007; 23: 391–6.
   Google Scholar
• Enoch RR, Stank° JP, Greiner SN., et al Mammary gland devel-opment as a sensitive endpoint after acute prenatal exposure to an atrazine metabolite mixture in female Long Evans rats. Env-iron Health Persp. 2007; 115: 5541–7. Atlanta: American Cancer Society, Inc
   Google Scholar
• Cohn BA, Wolff MA, Cirillo PM, Sholtz RI. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Persp. 2007; 115: 1406–14.
   PubMed Web of Science ®Google Scholar
• Boice, JD. Radiation and breast carcinogenesis. Med Ped Oncol. 2001; 26: 508–13.
   Google Scholar
• Preston DL, Mattsson A, Holmberg E., et al Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res. 2002; 158: 220–35.
   PubMed Web of Science ®Google Scholar
• Tokunaga M, Land CE, Tokuoka S., et al Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res. 1994; 138: 209–23.
   PubMed Web of Science ®Google Scholar
• Land CE, Tokunaga M, Koyama et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res. 2003; 160: 707–717.
   Google Scholar
• Pukkala E, Kesminiene A, Poliakov S., et al Breast cancer in Belarus and Ukraine aafter the Chernobyl accident. Int J Cancer. 2006; 119: 651–8.
   PubMed Web of Science ®Google Scholar
• Morin-Doody M, Lonstein JE, Stovall M., et al Breast cancer mortality after diagnostic radiography: findings from the U.S. Scoliosis Cohort Study. Spine. 2000; 25: 2052-63.
   Google Scholar
• Clemons MM, Loijens L, and Goss P. Breast cancer risk follow-ing irradiation for Hodgkin's disease. Cancer Treat Rev. 2000; 26: 291–300.
   PubMed Web of Science ®Google Scholar
• Tward JD, Wendland MM, Shrieve DC., et al The risk of sec-ondary malignancies over 30 years after the treatment of Non-Hodgkin's Lymphoma. Cancer. 2006; 107: 108–15.
   PubMed Web of Science ®Google Scholar
• Howe GR, McLaughlin” Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res. 1996; 145: 694–707.
   PubMed Web of Science ®Google Scholar
• Hildreth NG, Shore RE, Dvoretsky PM. The risk of breast cancer after irradiation of the thymus in infancy. N Eng1J Med. 1989; 321: 1281–4.
   PubMed Web of Science ®Google Scholar
• Ma H. Hill CK, Bernstein L, Ursin G. Low-dose medical radia-don exposure and breast cancer risk in women under age 50 years overall and by estrogen and progesterone status: results from a case-control and a case-case study. Breast Cancer Res Treat. 2008: 109:77–90.
   PubMed Web of Science ®Google Scholar
• Baer HJ, Schnitt SJ, Connolly JL., et al Adolescent diet and incidence of proliferative benign breast disease. Cancer Epi-demiol, Biomarkers Prey. 2003; 12: 1159–67.
   PubMed Web of Science ®Google Scholar
• Frazier AL, Ryan CT, Rockett H., et al Adolescent diet and risk of breast cancer. Breast Cancer Res. 2003; 5: R59–R64.
   PubMed Web of Science ®Google Scholar
• Murrill WB, Brown NM, Zhang JX., et al Prepubertal genestein exposure suppresses mammary cancer and enhances gland dif-ferentiation in rats. Carcinogenesis. 1996; 17: 1451–7.
   PubMed Web of Science ®Google Scholar
• Wu AH, Wan P, Hankin J., et al Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis. 2002; 23: 1491–6.
   PubMed Web of Science ®Google Scholar
• Lagerros Yr, Hsieh SF, Hsieh CC. Physical activity in adoles-cence and young adulthood and breast cancer risk: a quantita-tive review. Eur J Cancer Prey. 2004; 13: 5–22.
   PubMed Web of Science ®Google Scholar
• Love S. What kind of cancer is it? In: Dr. Susan Love's breast book. 4th ed. Cambridge (MA): Perseus Publishing; 2005. Chapter 20: p. 260-280.
   Google Scholar
• Daewood S, Cristofamilli M. What progress have we made in managing inflammatory breast cancer? (Disease/disorder overview). Oncology. 2007; 21: 673–85.
   PubMed Web of Science ®Google Scholar
• Mokbel K, Cutuli B. Heterogeneity of ductal carcinoma in situ and its effects on management. Lancet Oncol. 2006; 7: 756–65.
   PubMed Web of Science ®Google Scholar
• Hansen J. Elevated risk for male breast cancer after occupa-tional exposure to gasoline and vehicular combustion prod-ucts. Am J Ind Med. 2000; 37: 349–52.
   PubMed Web of Science ®Google Scholar
• Perou CM, Sorlie T, Eisen MB., et al Molecular portraits of human breast tumors. Nature. 2000; 406: 747–52.
   PubMed Web of Science ®Google Scholar
• Palli D, Masala G, Mariani-Costanini R., et al A gene-environ-ment interaction between occupation and BRCA1/BRCA2 mutations in male breast cancer? Eur J Cancer. 2004; 40: 2474–9.
   Google Scholar
• Smile T, Tibshirani Parker RJ., et al Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Nail Acad Sci U.S.A. 2003; 100: 8418–23.
   PubMed Web of Science ®Google Scholar
• Carey LA, Perou CM, Livasy CA., et al The poor prognosis basal-like breast cancer subtype is over-represented in young African-American women. J Am Med Assoc. 2006; 7: 2492–502.
   Google Scholar
• Ying MWL, Agrawal A, Cheung XL. The 'other half of breast cancer: a review of male breast cancer. J Men's Health Gender. 2005; 2: 406–14.
   Google Scholar
• Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prey. 2005; 14: 20–26.
   PubMed Web of Science ®Google Scholar
• De los Santos JF, Buchholz TA. Carcinogenesis of the male breast. Curr Treat Options Oncol. 2000; 1: 221–7.
   Google Scholar
• Honma N, Takubo K, Sawabe M., et al Estrogen-metabolizing enzymes in breast cancers from women over the age of 80 years. J Clin Endocrinol Metab. 2007; 91: 607–13.
   Web of Science ®Google Scholar
• International Agency for Research on Cancer. IARC Mono-graphs. 1987; (Suppl 7):280.
   Google Scholar
• National Toxicology Program. Tenth report on carcinogens. Research Triangle Park.:National Institute of Environmental Health Sciences, National Institutes of Health, 2002.
   Google Scholar
• Krieger N, Liiwy I, Aronowitz R, Bigby J., et al Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. Journal of Epidemiology and Commu-nity Health. 2005; 59: 740–8.
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epi-demiological studies. Lancet. 1996; 347: 1713-27.
   Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collabora-tive reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 1997; 350: 1047-59.
   Google Scholar
• International Agency for Research on Cancer. Hormonal con-traception and postmenopausal hormonal therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 72. Lyon: IARC 1999.
   Google Scholar
• Brinton LA, Brogan DR, Coates RJ., et al Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy. Menopause. 1998;5(3) :145–51.
   PubMed Web of Science ®Google Scholar
• Lund E, Bakken K, Dumeaux V., et al Hormone replacement therapy and breast cancer in former users of oral contracep-tives: the Norwegian women and cancer study. Int J Cancer. 2007; 121: 645–8.
   PubMed Web of Science ®Google Scholar
• Shantakumar S, Terry MB, Paykin A., et al Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Am J Epi-demiol. 2007; 165: 1187–98.
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women's Health Initiative Investiga-tors. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc. 2002; 288 (3): 321–33.
   Google Scholar
• Anderson GL, Limacher M. Effects of conjugated equine estro-gen in postmenopausal women with hysteresctomy: The Women's Health Initiative randomized controlled study. J Am Med Assoc. 2004; 291: 1701–12.
   PubMed Web of Science ®Google Scholar
• Holmberg L, Anderson H. HABITS (hormonal replacement therapy after breast cancer-is it safe?): trial stopped. Lancet. 2004; 363: 453–5.
   PubMed Web of Science ®Google Scholar
• Million Women Study Collaborators. Breast cancer and hor-mone-replacement therapy in the Million Women Study. Lancet. 2003; 362: 419–27.
   Google Scholar
• Borgquist S, Anagnostaki L, Jirstom K., et al Breast tumours fol-lowing combined hormone replacement therapy express favorable prognostic factors. Int J Cancer. 2007; 120: 2202–7.
   PubMed Web of Science ®Google Scholar
• Reeves GK, Beral V, Green J., et al Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol. 2006; 7: 910–18.
   PubMed Web of Science ®Google Scholar
• Schuetz F, Diel IJ, Pueschel M., et al Reduced incidence of dis-tant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. Amer-ican Journal of Obstetrics & Gynecology. 2007; 196: e1–9.
   PubMedGoogle Scholar
• Kumle M, Weiderpass E, Braaten T., et al Use of oral contra-ceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prey. 2002; 11: 1375–81.
   PubMed Web of Science ®Google Scholar
• Althuis MD, Brogan DD, Coates RJ., et al Breast cancers among very young premenopausal women (United States). Cancer Causes Control. 2003; 14: 151–60.
   PubMed Web of Science ®Google Scholar
• Deligeroroglou E, Michailidis E, Creatsas G. Oral contracep-tives and reproductive system cancer. Annals Ann NYAcad Sci. 2003; 997: 199–208.
   PubMed Web of Science ®Google Scholar
• Newcomer LM, Newcomb PA, Trentham-Dietz A., et al Oral contraceptive use and risk of breast cancer by histologic type. Int J Cancer. 2003; 106: 961–4.
   PubMed Web of Science ®Google Scholar
• Delort L, Kwiatkowski F, Chalabi N., et al Risk factors for early age at breast cancer onset: the “COSA Program” population based study. Anticancer Res. 2007; 27: 1087–94.
   PubMed Web of Science ®Google Scholar
• Grabrick DM, Hartmann LC, Cerhan RJ., et al Risk of breast cancer with oral contraceptive use in women with a family his-tory of breast cancer. J Am Med Assoc. 2000; 284: 1791–8.
   PubMed Web of Science ®Google Scholar
• Narod SA, Dube MP, Klign J., et al Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2002; 94: 1773–9.
   PubMed Web of Science ®Google Scholar
• Haile RW, Thomas DC, McGuire V., et al BRCA1 and BRCA2 mutation carriers, oral contraceptive use and breast cancer before age 50. Cancer Epidemiol Biomarkers Prey. 2006; 15: 1863-70.
   Google Scholar
• Sweeney C, Giuliano AR, Baumgartner KB., et al Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women. Int J Cancer 2007; 121: 2517-2523.
   Google Scholar
• Herbst AL, Scully RE. Adenocarcinoma of the vagina in ado-lescence: a report of seven cases including six clear cell carci-nomas (so-called mesonephromas). Cancer. 1970; 25: 745–57.
   PubMed Web of Science ®Google Scholar
• Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971; 284: 878–81.
   PubMed Web of Science ®Google Scholar
• Bibbo M, Gill WB, Azizi F., et al Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol J. 1977; 49: 1–8.
   PubMed Web of Science ®Google Scholar
• Palmer JR, Wise LA, Hatch EE., et al Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Bio-markers Prey. 2006; 15: 1509–14.
   PubMed Web of Science ®Google Scholar
• Tiwary CM. Premature sexual development in children follow-ing the use of estrogen-or placenta-containing hair products. Clin Ped. 1998; 27: 733–9.
   Google Scholar
• Tiwary CM, Ward JA. Use of hair products containing hormone or placenta by U.S. military personnel. J Ped Endocrinol Metab. 2003; 16: 1025-32.
   Google Scholar
• Li ST, Lozano P, Grossman DC, Graham E. Hormone-contain-ing hair product use in prepubertal children. Arch Ped Adol Med. 2002; 156: 85–6.
   PubMedGoogle Scholar
• Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasi S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an interna-tional case-control study. Int J Cancer. 2002; 46: 796–800.
   Google Scholar
• Donovan M, Tiwary CM, Axelrod D., et al Personal care prod-ucts that contain estrogens or xenoestrogens may increase breast cancer risk. Med Hypoth. 2007; 68: 756–66.
   PubMed Web of Science ®Google Scholar
• Rice S, Whitehead SA. Phytoestrogens and breast cancer: pro-moters or protectors? Endoc Relat Cancer. 2006; 13: 995–1015.
   Google Scholar
• Jaga K, Duvvi H. Risk reduction for DDT toxicity and carcino-genesis through dietary modification. Journal of the Royal Society for the Promotion of Health. 2001; 121: 107–13.
   PubMedGoogle Scholar
• Adlercreutz H. Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol. 2003; 83: 113–18.
   Web of Science ®Google Scholar
• Murata M, Midorikawa K, Koh M., et al Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estro-gen-sensitive organs. Biochemistry. 2004; 43: 2569–77.
   PubMed Web of Science ®Google Scholar
• Liu B, Edgerton S, Yang X., et al Low dose dietary phytoestro-gen abrogates tamoxifen-associated mammary tumor preven-tion. Cancer Res. 2005; 65: 879–86.
   PubMed Web of Science ®Google Scholar
• Constantinou Al, White BE, Tonetti D., et al The soy isoflavone daidezein improves the capacity of tamoxifen to prevent mam-mary tumors. Eur J Cancer. 2005; 41: 647–54.
   PubMed Web of Science ®Google Scholar
• National Research Council. Effects on reproduction and devel-opment. In: Hormonally Active Agents in the Environment. Washington: National Academy of Sciences; 1999. Chapter 5, p 119-170.
   Google Scholar
• Erickson BE. Tests of endocrine disruptors delayed. Chem Eng News 2008; 86: 60–2.
   Web of Science ®Google Scholar
• Davis DL, Bradlow HL, Wolff M., et al Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Persp. 1993; 101 (5): 371–7.
   Google Scholar
• Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonyl-phenol: An estrogenic xenobiotic released from “modified” polystyrene. Environ Health Persp. 1991; 92: 167–73.
   PubMed Web of Science ®Google Scholar
• Soto AM, Chung XL, Sonnenschein C. The pesticides endo-sulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Persp. 1994; 102: 380–3.
   PubMed Web of Science ®Google Scholar
• Commission of the European Communities. Commission staff working document on implementation of the community strat-egy for endocrine disruptors: a range of substances suspected of interfering with the hormone systems of humans and wildlife [Internet]. 2004. Available from: http:ec.europa.eu/environment/endocrine/documents/sec_2004_1372_en.pdf
   Google Scholar
• Brody JG, Rudel RA, Melly SJ, Maxwell NI. Endocrine disrup-tors and breast cancer. For Appl Res Public Pol. 1998; 13 (3): 24–31.
   Google Scholar
• McKelvey W, Brody JG, Aschengrau A, Swartz CH. Association between residence on Cape Cod, Massachusetts, and breast cancer. Ann Epidemiol. 2004; 14: 89–94.
   PubMed Web of Science ®Google Scholar
• Rudel RA, Geno P, Melly SJ., et al Identification of alkylphenols and other estrogenic phenolic compounds in wastewater, sep-tage, and groundwater on Cape Cod, Massachusetts. Environ Sci Technol. 1998; 32 (7): 861–9.
   Web of Science ®Google Scholar
• Kulkarni PS, Crespo JG, Afonso CAM. Dioxin sources and cur-rent remediation technologies-A review. Environ Int. 2008 :34: 139–153.
   PubMed Web of Science ®Google Scholar
• IARC (International Agency for Research on Cancer) 1997. Polychlorinated Dibenzo-para-dioxins and Polychlorinated Dibenzofurans. IARC Monogr Eval Carcinog Risks Hum 69.
   Google Scholar
• Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Chlorinated Dibenzo-p-Dioxins. Public Health Service, U.S. Department of Health and Human Services, Atlanta, GA. 1998.
   Google Scholar
• Schecter A, Birnbaum L, Rryan JJ, Constable JD. Dioxins: An overview. Environ Res. 2006: 101:419–426.
   PubMed Web of Science ®Google Scholar
• Massart F, Harrell JC, Federico G., et al Human breast milk and xenoestrogen exposure: A possible impact on human health. J Perinatol. 2005; 25: 282–8.
   PubMedGoogle Scholar
• Warner MB, Eskenazi B, Mocarelli P., et al Serum dioxin con-centrations and breast cancer risk in the Seveso Women's Health Study. Environ Health Persp. 2002; 110: 625–8.
   PubMed Web of Science ®Google Scholar
• Manz A, Berger J, Dwyer JH., et al Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet. 1991; 338: 959–64.
   PubMed Web of Science ®Google Scholar
• Lewis BC, Hudgins S, Lewis A., et al In utero and lactational treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs mammary gland differentiation but does not block the response to exogenous estrogen in the postpubertal rat. Toxi-cological Science. 2001; 62: 63–74.
   Google Scholar
• Simcox NJ, Fenske RA, Wolz SA., et al Pesticides in household dust and soil: exposure pathways for children of agricultural families. Environ Health Persp. 1995; 103: 1126–34.
   PubMed Web of Science ®Google Scholar
• Beard J. DDT and human health. Sci Total Environ. 2006; 355: 78–89.
   PubMed Web of Science ®Google Scholar
• World Health Organization Roll Back Malaria Partnership. Final DDT agreement endorses RBM objectives. Roll Back Malaria News 3 [Internet]. 2001 Feb. Available from: www.rbm.who.int/
   Google Scholar
• Zheng T, Holford T, Mayne S., et al DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epi-demiol. 1999; 150: 453–8.
   PubMed Web of Science ®Google Scholar
• Rogan WJ. Pollutants in breast milk. Arch Ped Adol Med. 1996; 150: 81–90.
   PubMedGoogle Scholar
• Gammon MD, Wolf MS, Neugut AI., et al Environmental toxins and breast cancer on Long Island. II.Organochlorine com-pound levels in blood. Cancer Epidemiol Biomarkers Prey. 2002; 11: 677–85.
   PubMed Web of Science ®Google Scholar
• Robison AK, Sirbasku DA, Stancel GM. DDT supports the growth of an estrogen-responsive tumor. Toxicol Lett. 1985; 27: 109–13.
   PubMed Web of Science ®Google Scholar
• Scribner JD, Mottet NK. DDT acceleration of mammary gland tumors induced in the male Sprague-Dawley rat by 2-acetami-dophenanthrene. Carcinogenesis. 1981; 2: 1235–9.
   PubMed Web of Science ®Google Scholar
• Pujol P, Hilsenbeck SG, Chamness GC, Elledge RM. Rising levels of estrogen receptor in breast cancer over 2 decades. Cancer. 1994; 74 (5): 1601–6.
   PubMed Web of Science ®Google Scholar
• Woolcott CG, Aronson KJ, Hanna WM., et al Organochlorines and breast cancer risk by receptor status, tumor size and grade (Canada). Cancer Causes Control. 2001; 12: 395–404.
   PubMed Web of Science ®Google Scholar
• Robinson PE, Mack GA, Remmers J., et al Trends of PCB, hexachlorobenzene, and benzene hexachloride levels in the adipose tissue of the U.S. population. Environ Res. 1990; 53: 175–92.
   Google Scholar
• Hagmar L, Wallin E, Vessby B., et al Intra-individual variations and time trends 1991-2001 in human serum levels of PCB, DDE, and hexchlorobenzene. Chemosphere. 2006; 64: 1507-13.
   Google Scholar
• Choi AL, Levy JI, Dockery DW., et al Does living near a Super-fund site contribute to higher polychlorinated biphenyl (PCB) exposure? Environ Health Persp. 2006; 114: 1092–8.
   Google Scholar
• Connor K, Ramamoorthy K, Moore M., et al Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestro-gens: Structure-activity relationships. Toxicol App Pharmacol. 1997; 145: 111–23.
   PubMed Web of Science ®Google Scholar
• Braathen M, Mortensen AS, Sandvik M., et al Estrogenic effects of selected hydroxy polychlorinated biphenyl congeners in pri-mary culture of Atlantic salmon (Salmo salar) hepatocytes. Arch Environ Contam Toxicol. 2009; 56: 111–122.
   PubMed Web of Science ®Google Scholar
• Charlier CJ, Albert Al, Zhang L., et al Polychlorinated biphenyls contamination in women with breast cancer. Clin Chim Acta. 2004; 347: 177–81.
   PubMed Web of Science ®Google Scholar
• Aronson KJ, Miller AB, Woolcott CG., et al Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Bio-markers Prey. 2000; 9: 55–63.
   PubMed Web of Science ®Google Scholar
• Decastro BR, Korrick SA, Spengler JD., et al Estrogenic activity of polychlorinated biphenyls present in human tissue and the environment. Environ Sci Technol. 2006; 40: 2819–2825.
   PubMed Web of Science ®Google Scholar
• Muscat JE, Britton JA, Djordjevic MV., et al Adipose concentra-tions of organochlorine compounds and breast cancer recur-rence in Long Island, New York. Cancer Epidemiol Biomarkers Prey. 2003; 12: 1474–8.
   PubMed Web of Science ®Google Scholar
• Salehi F, Turner MC, Phillips KP., et al Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors. J Toxicol Environ Health - Pt B: Grit Rev. 2008; 11: 276–300.
   PubMed Web of Science ®Google Scholar
• Laden F, Collman G, Iwamoto K., et al 1,1-Dichloro-2,2-bis(pchloroophenyl) ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst. 2001; 93: 768–76.
   Google Scholar
• Gierthy JF, Arcaro KF, Floyd M. Assessment of PCB estrogenic-ity in a human breast cancer cell line. Chemosphere. 1997; 34: 1495–1505.
   PubMed Web of Science ®Google Scholar
• Andersson PL, Blom A, Johannisson A., et al Assessment of PCBs and hydroxylated PCBs as potential xenoestrogens: In vitro studies based on MCF-7 cell proliferation and induction of vitellogenin in primary culture of rainbow trout hepatocytes. Arch Environ Comtam Toxicol. 1999; 37: 145–50.
   PubMed Web of Science ®Google Scholar
• Hatakeyama M, Matsumura E Correlation between the activa-tion of Neu tyrosine kinase and promotion of foci formation induced by selected organochlorine compounds in the MCF-7 model system. J Biochem Mol Toxicol. 1999;13(6) :296–302.
   PubMed Web of Science ®Google Scholar
• Teitelbaum SL, Gammon MD, Britton JA., et al Reported resi-dential pesticide use and breast cancer risk on Long Island, New York. Am J Epidemiol. 2006; 165: 643–51.
   PubMed Web of Science ®Google Scholar
• O'Connor JC, Plowchalk DR, Van Pelt CS., et al Role of pro-lactin in chloro-S-triazine rat mammary tumorigenesis. Drug Chem Toxicol. 2000; 23: 575–601.
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency. Cyanazine (Bladex) terms and conditions of registration. Fed Reg 1999; 64: 3511–13.
   Google Scholar
• U.S. Environmental Protection Agency, Office of Pesticide Pro-grams. Atrazine: third report of the Hazard Identification Assessment Review Committee, 2000 [Internet]. 2007 July 15. Available from: www.epa.gov/pesticides/factsheets/atrazine_ background.htm
   Google Scholar
• Villanueva CM, Durand G, CouttE MB., et al Atrazine in munic-ipal drinking water and risk of low birth weight, preterm deliv-ery, and small-for-gestational-age status. Occup Environ Med. 2005; 62: 400–5.
   PubMed Web of Science ®Google Scholar
• Hua WY, Bennett ER, Maio X-S., et al Seasonality effects on pharmaceuticals and 5-triazine herbicides in wastewater efflu-ent and surface water from the Canadian side of the upper Detroit River. Environ Toxicol Chem. 2006; 25: 2356-65.
   Google Scholar
• Miller S, Sweet C, Depinto J, Hornbuckle K. Atrazine and nutrients in precipitation from the Lake Michigan mass bal-ance study. Environ Sci Technol. 2000; 34: 55–61.
   Web of Science ®Google Scholar
• Kettles MA, Browning SR, Prince TS, Hortsman SW. Triazine herbicide exposure and breast cancer incidence: an ecological study of Kentucky counties. Environ Health Persp. 1997; 105: 1222–7.
   PubMed Web of Science ®Google Scholar
• Hayes T, Haston K, Tsui M., et al Atrazine-induced hermaphoditism at 0.1ppb in American leopard frogs (Rana pipiens): laboratory and field evidence. Environ Health Persp. 2003; 111: 568–75.
   Google Scholar
• Cooper RL, Stoker TE, Tyrey L., et al Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol Sci. 2000; 53: 297–307.
   PubMed Web of Science ®Google Scholar
• Sanderson JT, Letcher RJ, Heneweer M., et al Effects of chloro-S-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes. Environ Health Persp. 2001; 109: 1027–31.
   PubMed Web of Science ®Google Scholar
• Fan WQ, Yanase T, Morinaga H., et al Atrazine-induced aro-matase expression in SF-1 dependent: implications for endocrine disruption in wildlife and reproductive cancers in humans. Environ Health Rep. 2007; 115: 720–7.
   Web of Science ®Google Scholar
• Nabholtz JM. Aromatase inhibitors in the management of early breast cancer. Eur J Surg Oncol. 2008; 34: 1199–1207.
   PubMed Web of Science ®Google Scholar
• Raynor JL, Enoch RR, Fenton SE. Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. Toxicol Sci. 2005; 87: 255–66.
   PubMed Web of Science ®Google Scholar
• Siegel BZ. Pesticide hazard assessment project 1981-1984. Honolulu, HI: Pacific Biomedical Research Center, University of Hawaii; 1995. p. 1-63.
   Google Scholar
• Maskarinec G, Zhang Y, Takata Y., et al Trends of breast cancer incidence and risk factor prevalence over 25 years. Breast Cancer Res Treat. 2006; 98: 45–54.
   PubMed Web of Science ®Google Scholar
• Environmental Working Group. Body burden 2: the pollution in newborns. [Internet] 2005. Available from: www.ewg.org/ reports/body burden2.
   Google Scholar
• Khanjani N, English DR, Sim MR. An ecological study of organochlorine pesticides and breast cancer in rural Victoria, Australia. Arch Environ Comtam Toxicol. 2006; 50: 452–61.
   PubMed Web of Science ®Google Scholar
• Cassidy RA, Natarajan S, Vaughan GM. The link between the insecticide heptachlor epoxide, estradiol, and breast cancer. Breast Cancer Res Treat. 2005; 90: 55–64.
   PubMed Web of Science ®Google Scholar
• Dich J, Zahm SH, Hanberg A, Adami HO. Pesticides (hep-tachlor) and cancer. Cancer Causes Control. 1997; 8: 420–43.
   PubMed Web of Science ®Google Scholar
• Agency for Toxic Substances and Disease Registry. Fact sheet [Internet]. 2004 Mar 17. Available from: www.atsdr.cdc.gov/ tfactsl .html
   Google Scholar
• Hoyer AP, Grandjean P, Jorgensen T., et al Organochlorine exposure and risk of breast cancer. Lancet. 1998;352 (9143): 1816–20.
   PubMed Web of Science ®Google Scholar
• Hoyer AP, Jorgensen T, Brock JW, Grandjean P. Organochlo-rine exposure and breast cancer survival. J Clin Epidemiol. 2000; 53: 323–30.
   PubMed Web of Science ®Google Scholar
• Andersen HR, Vinggaard AM, Rasmussen TH., et al Effects of currently used pesticides in assays for estrogenicity, andro-genicity, and aromatase activity in vitro. Toxicol App Pharma-col. 2002; 179: 1–12.
   PubMed Web of Science ®Google Scholar
• Engel LS, Hill DA, Hoppin JA., et al Pesticide use and breast cancer risk among farmers' wives in the Agricultural Health Study. Am J Epidemiol. 2005; 161: 121–35.
   PubMed Web of Science ®Google Scholar
• Alexander BH, Mandel JS, Baker BA., et al Biomonitoring of 2,4-dichlorophenoxyaceetic acid exposure and dose in farm families. Environ Health Persp. 2007; 115: 370–6.
   PubMed Web of Science ®Google Scholar
• Morris JJ, Seifter E. The role of aromatic hydrocarbons in the genesis of breast cancer. Med Hypoth. 1992; 38: 177–84.
   PubMed Web of Science ®Google Scholar
• Pliskova M, Vondracek J, Vojtesek B., et al Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events. Toxicol Sci. 2005; 83: 246.
   PubMed Web of Science ®Google Scholar
• Kemp MQ, Liu W, Thorne PA., et al Induction of the transfer-ring receptor gene by benzoapyrene in breast cancer MCF-7 cells: potential as a biomarker of PAH exposure. Environ Mol Mut. 2006; 47: 518–26.
   PubMed Web of Science ®Google Scholar
• Ralston SL, Coffing SL, Seidel A., et al Stereoselective activa-tion of dibenzo [a,1] pyrene and its trans-11,12-dihydriol to fjord region 11,12-diol 13,14 epoxides in a human mammary carci-noma MCF-7 cell-mediated V79 cell mutation assay. Chem Res Toxicol. 1997; 10: 687–93.
   PubMed Web of Science ®Google Scholar
• Gammon MD, Santella RM, Neugut Al., et al Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prey. 2002; 11: 677–85.
   PubMed Web of Science ®Google Scholar
• Rundle A, Tang D, Hibshoosh H., et al The relationship between genetic damage from polycyclic aromatic hydrocar-bons in breast tissue and breast cancer. Carcinogenesis. 2000;21 ( 7) :1281–9.
   PubMed Web of Science ®Google Scholar
• Petralia SA, Vena JE, Freudenheim JL., et al Risk of pre-menopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scand J Work Environ Health. 1999; 25: 215–21.
   PubMed Web of Science ®Google Scholar
• California Environmental Protection Agency, Air Resources Board. Proposed identification of environmental tobacco smoke as a toxic air contaminant: Appendix A, list of known ETS con-stituents [Internet]. 2005 June. Available from: http:www.oehha.ca.gov/air/environmental_tobacco/pdf/app3partb2005.pdf
   Google Scholar
• Kilthau GE Cancer risk in relation to radioactivity in tobacco. Radiol Tech. 1996; 67 (3): 217–22.
   Google Scholar
• Hanaoka T, Yamamoto S, Sobue T., et al Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Disease Study Group: active and passive smoking and breast cancer risk in middle-aged Japanese women. Int J Cancer. 2005; 114: 317–22.
   PubMed Web of Science ®Google Scholar
• Reynolds P, Hurley S, Goldberg DE., et al Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst. 2004; 96: 29–37.
   PubMed Web of Science ®Google Scholar
• Band PR, Le ND, Fang R, Deschamps M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet. 2002; 360: 1033–4.
   PubMed Web of Science ®Google Scholar
• Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Ciga-rette smoking and risk of fatal breast cancer. Am J Epidemiol. 1994; 139 (10): 1001–7.
   PubMed Web of Science ®Google Scholar
• Marcus PM, Newman B, Millikan RC., et al The associations of adolescent cigarette smoking, alcoholic beverage consump-tion, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes Control. 2000; 11 (3): 271–8.
   PubMed Web of Science ®Google Scholar
• Johnson KC, Hu J, Mao Y. Passive and active smoking and breast cancer risk in Canada, 1994-1997: The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control. 2000; 11: 211–21.
   PubMed Web of Science ®Google Scholar
• Gram IT, Braaten T, Terry PD., et al Breast cancer among women who started smoking as teenagers. Cancer Epidemiol Biomarkers Prey. 2005; 14: 61–6.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Curtin K, Giuliano AR., et al Active and passive smoking, IL6, ESR1, and breast cancer risk. Breast Cancer Res Treat. 2008; 109: 101–111.
   PubMed Web of Science ®Google Scholar
• Morabia A, Bernstein M, Heritier S, Khatchartrian N. Relation of breast cancer to active and passive exposure to tobacco smoke. Am J Epidemiol. 1996; 143: 918–28.
   PubMed Web of Science ®Google Scholar
• California Environmental Protection Agency, Air Resources Board. Proposed identification of environmental tobacco smoke as a toxic air contaminant. Part B: Health effects assess-ment for environmental tobacco smoke. [Internet] 2005. Avail-able from: ww.arb.ca.gov/toxics/ets/finalreport/finalreport. him
   Google Scholar
• Lee PN, Hamling J. Environmental tobacco smoke exposure and risk of breast cancer in nonsmoking women: A review with meta-analyses. Inhal Toxicol. 2006; 18: 1053–70.
   PubMed Web of Science ®Google Scholar
• Burridge E. Bisphenol A: surging polycarbonate in Asia has boosted bisphenol A's fortunes. Eur Chem News. 2004; 81: 17.
   Google Scholar
• Matsumoto H, Adachi S, Suzuki Y Bisphenol A in ambient air particulates responsible for the proliferation of MCF-7 human breast cells and its concentration changes over 6 months. Arch Environ Contam Toxicol. 2005; 48: 459–66.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Mozaz S, Lopez de Alda M, Barcelo D. Analysis of bisphenol A in natural waters by means of an optical imm-munosensor. Water Res. 2005; 39: 5071–9.
   Google Scholar
• Brotons JA, Olea-Serrano MF, Villalobos M., et al Xenoestro-gens released from lacquer coatings in food cans. Environ Health Persp. 1995; 103: 608–12.
   PubMed Web of Science ®Google Scholar
• Ikezuki Y, Tsutsumi O. Takai Y, et al. Determination of bisphe-nol A concentrations in human biological fluids reveals signifi-cant early prenatal exposure. Hum Reprod. 2002; 17: 2839–41.
   Google Scholar
• Schonfelder G, Wittfoht W, Hopp H., et al Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Env-iron Health Persp. 2002; 110: A703–7.
   Web of Science ®Google Scholar
• Maffini MV, Rubin BS, Sonnenschein C, Soto AM. Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol Cell Endocrinol. 2006;254-255: 179-86.
   Google Scholar
• Wadia PR, Vandenberg LN, Schaeberle CM., et al Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse species. Environ Health Persp. 2007; 115: 80–6.
   PubMedGoogle Scholar
• Durando M, Kass L, Piva J., et al Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Persp. 2007; 115: 592–8.
   PubMedGoogle Scholar
• Rivas A, Lacroix M, Olea-Serrano F., et al Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2002; 82: 45–53.
   PubMed Web of Science ®Google Scholar
• Welshons WV, Nagel SC, vom Saal FS. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology. 2006; 147: S56–9.
   Google Scholar
• Watson CS, Bulayeva NN, Wozniak AL, Finnerty CC. Signaling from the membrane via membrane estrogen receptor-alpha: estrogens, xenoestrogens, and phytoestrogens. Steroids. 2005; 70: 364–71.
   PubMed Web of Science ®Google Scholar
• Wozniak AL, Bulayeva NN, Watson CS. Xenoestrogens at pico-molar to nanomolar concentrations trigger membrane estro-gen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Persp. 2005; 113: 431–9.
   PubMed Web of Science ®Google Scholar
• Iso T, Watanabe T, Iwamoto T., et al DNA damage caused by bisphenol A and estradiol through estrogenic activity. Biol Pharm Bull. 2006; 29: 206–10.
   PubMed Web of Science ®Google Scholar
• Slack RJ, Gronow JR, Voulvoulis N. Household hazardous waste in municipal landfills: contaminants in leachate. Sci Total Env-iron. 2005; 337: 119–37.
   PubMed Web of Science ®Google Scholar
• Soto AM, Sonnenschein C, Chung XL., et al The E-SCREEN Assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Persp. 2003;103 (Suppl 7):113–22.
   Google Scholar
• Thomas P, Dong J. Binding and activation of the seven-trans-membrane estrogen receptor GPR30 by environmental estro-gens: a potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol. 2006; 102: 175–9.
   PubMed Web of Science ®Google Scholar
• Moon HJ, Han SY, Shin JH., et al Gestational exposure to nonylphenol causes precocious mammary gland develop-ment in female rat offspring. J Reprod Dev. 2007; 53: 333–44.
   PubMed Web of Science ®Google Scholar
• Acevedo R, Parnell PG, Villaneuva H., et al The contribution of hepatic steroid metabolism to serum estradiol and estriol con-centrations in nonylphenol treated MMTV neu mice and its potential effects on breast cancer incidence and latency. J Appl Toxicol. 2005; 25: 339–53.
   PubMed Web of Science ®Google Scholar
• Ionescu JG, Novotny J, Stejskal V., et al Increased levels of tran-sition metals in breast cancer tissue. Neuroendocrinol Lett. 2006;27(Suppl 1):36–9.
   PubMedGoogle Scholar
• Wu HDI, Chou SY, Chen DR, Kuo HW. Differentiation of serum levels of trace elements in normal and malignant breast patients. Biol Trace Elem Res. 2006; 113: 9–18.
   PubMed Web of Science ®Google Scholar
• Martin MB, Reiter R, Pham T., et al Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology. 2003; 144: 2425-36.
   Google Scholar
• Brama M, Gnessi L, Basciani S., et al Cadmium induces mito-genic signaling in breast cancer cell by an Eralpha-dependent mechanism. Mol Cell Endocrinol. 2007; 264: 102–8.
   PubMed Web of Science ®Google Scholar
• Sukocheva OA, Yang Y, Gierthy JF, Seegal RF. Methyl mercury influences growth-related signaling in MCF-7 breast cancer cells. Environ Toxicol. 2005; 20: 32–44.
   PubMed Web of Science ®Google Scholar
• Rudel RA, Brody JG, Spengler JD., et al Methods to detect selected potential mammary carcinogens and endocrine dis-ruptors in commercial and residential air and dust samples. J Air Waste Manag Association. 2001; 51 (4): 499–513.
   Web of Science ®Google Scholar
• Kato K, Silva MJ, Reidy JA., et al Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxhexyl) phthalate as biomark-ers for human exposure assessment to di-(2-ethylhexyl) phtha-late. Environ Health Persp. 2003; 112: 327–30.
   Web of Science ®Google Scholar
• Foster PM. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl. 2005; 29: 140–7.
   PubMedGoogle Scholar
• Latini G, Del Vecchio A, Massaro M., et al Phthalate exposure and male infertility. Toxicology. 2006; 226: 90–8.
   PubMed Web of Science ®Google Scholar
• Swan SH, Main KM, Liu F., et al Decrease in anogenital dis-tance among male infants with prenatal phthalate exposure. Environ Health Persp. 2005; 113: 1056–61.
   PubMed Web of Science ®Google Scholar
• Jobling S, Reynolds T, White R., et al A variety of environmen-tally persistent chemicals, including some phthalate plasticiz-ers, are weakly estrogenic. Environ Health Persp. 1995; 103: 582–7.
   PubMed Web of Science ®Google Scholar
• Kang SC, Lee BM. DNA methylation of estrogen receptor agene by phthalates. J Toxicol Environ Health Part A. 2005; 68: 1995–2003.
   PubMed Web of Science ®Google Scholar
• Kim IY, Han SY, Moon A. Phthalates inhibit tamoxifen-induced apoptosis in MCF-7 human breast cancer cells. J Toxicol Envi-ron Health. 2004; 67: 2025-35.
   Google Scholar
• Lovekamp-Swan T, Davis BJ. Mechanisms of phthalate ester toxicity in female reproductive system. Environ Health Persp. 2003; 111: 139–45.
   PubMed Web of Science ®Google Scholar
• Jiang JT, Ma L, Yuan L., et al Study on developmental abnor-malities in hypospadiac male rats induced by maternal exposure to di-n-butyl phthalate (DBP). Toxicology. 2007; 232: 286–93.
   PubMed Web of Science ®Google Scholar
• Borch J, Axelstad M, Vinggaard AM, Dalgaard M. Mechanisms underlying the anti-androgenic effects of diethylhexyl phtha-late in fetal rat testis. Toxicology. 2006; 223: 144–55.
   PubMed Web of Science ®Google Scholar
• Fang H, Tong W, Branham WS, Moland, et al. Study of 202 nat-ural, synthetic, and environmental chemicals for binding to the androgen receptor. Chem Res Toxicol. 2003; 16: 1338–58.
   Google Scholar
• Cox DG, Blanche H, Pearce CL., et al A comprehensive analy-sis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort (BCP3). Breast Cancer Res. 2006; 8: R54.
   PubMedGoogle Scholar
• Darbre PD, Aljarrah A, Miller WR., et al Concentrations of parabens in human breast tumours. J Appl Toxicol. 2004; 24: 5–13.
   PubMed Web of Science ®Google Scholar
• Rastogi SC, Schouten A, Dekruijf N, Weijland JW. Contents of methylparaben, ethylparaben, propylparaben, butylparaben and benzylparaben in cosmetic products. Contact Dermatitis. 1995; 32: 28–30.
   PubMed Web of Science ®Google Scholar
• Ye X, Bishop AM, Reidy JA., et al Parabens as urinary biomark-ers of exposure in humans. Environ Health Persp. 2006; 114: 1843–6.
   PubMed Web of Science ®Google Scholar
• Byford JR, Shaw LE, Drew MGB., et al Oestrogenic activity of parabens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol. 2002; 80: 49–60.
   PubMed Web of Science ®Google Scholar
• Hayden CG, Roberts MS, Benson HA. Systemic absorption of sunscreen after topical application. Lancet. 1997; 350: 853–64.
   Google Scholar
• Schlumpf M, Cotton B, Conscience M., et al In vitro and in vivo estrogenicity of UV screens. Environ Health Persp. 2001; 109 (3): 239–44.
   PubMed Web of Science ®Google Scholar
• Heneweer M, Muusse M, van den Berg M., et al Additive estro-genic effects of mixtures of frequently used UV filters on pS2-gene transcription in MCF-7 cells. Toxicol App Pharmacol. 2005; 208: 170–7.
   PubMed Web of Science ®Google Scholar
• Brand RM, McMahon L, Jendrzejewski JL, Charron AR. Trans-dermal absorption of the herbicide 2,4-dichlorophenoxyacetic acid is enhanced by both ethanol consumption and sunscreen application. Food Chem Toxicol. 2007; 45: 93–7.
   PubMed Web of Science ®Google Scholar
• Hanrahan C. CRS Report for Congress: R520142: The Euro-pean Union's ban on hormone-treated meat [Internet]. 2007. Available from: www.ncseonline.org/NLE/ CRSreports/Agri-culture/ag-63.cfm
   Google Scholar
• Eaton ML. Ethics analysis applied to Monsanto and the label-ing of rbST. In: Ethics and the Business of Bioscience. Palo Alto, CA:Stanford University Press.pp. 70-105.
   Google Scholar
• Outwater JL, Nicholson A, Barnard N. Dairy products and breast cancer: the IGF-1, estrogen and bGH hypothesis. Med Hypoth. 1997; 48: 453–61.
   PubMed Web of Science ®Google Scholar
• Hankinson S, Willett WC, Colditz GA., et al Circulating con-centrations of insulin-like growth factor 1 and risk of breast cancer. Lancet. 1998; 351: 1393–6.
   PubMed Web of Science ®Google Scholar
• Daxenberger, A, Bernhard BH, Sauerwein H. Increased milk levels of insulin-like growth factor 1 (IGF-1) for the identifica-tion of bovine somatotropin (bST) treated cows. The Analyst. 1998; 123: 2429-35.
   Google Scholar
• Toniolo P, Bruning PF, Akhmedkhanov A., et al Serum insulin-like growth factor-1 and breast cancer. Int J Cancer. 2000; 88: 828–832.
   PubMed Web of Science ®Google Scholar
• Allen NE, Roddam AW, Allen DS., et al A prospective study of serum insulin-like growth factor-I (IGF-1), IGF-II, IGF-binding protein-3 and breast cancer risk. Brit J Cancer. 2005; 92: 1283–7.
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Holly JM, Pollak MN, Hankinson SE. Cir-culating levels of insulin-like growth factors, their binding pro-teins, and breast cancer risk. Cancer Epidemiol Biomarkers Prey. 2005; 14: 699–704.
   PubMed Web of Science ®Google Scholar
• Ciftci K, Su J, Trovitch PB. Growth factors and chemothera-peutic modulation of breast cancer cells. J Pharm Pharmacol. 2003; 55: 1135–41.
   PubMed Web of Science ®Google Scholar
• Furstenberger G, Morant R, Senn HJ. Insulin-like growth fac-tors and breast cancer. Onkologie. 2003; 26: 290–4.
   PubMedGoogle Scholar
• Holly J. Insulin-like growth factor 1 and new opportunities for cancer prevention. Lancet. 1998; 351: 1373–5.
   PubMed Web of Science ®Google Scholar
• Macaulay VM. Insulin-like growth factors and cancer. Brit J Cancer. 1998; 65: 311–20.
   Google Scholar
• Resnicoff M, Baserga R. The insulin-like growth factor I recep-tor protects tumor cells from apoptosis in vivo. Cancer Res. 1995; 55: 2463–9.
   PubMed Web of Science ®Google Scholar
• Xian C. Degradation of IGF-1 in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein. J Endocrinol. 1995; 146: 215–25
   PubMed Web of Science ®Google Scholar
• Leffers H, Naesby M, Vendelbo B., et al Oestrogenic potencies of zeranol, oestradiol, diethylstilbestrol, bisphenol-A and genis-tein: implications for exposure assessment of potential endocrine disrupters. Hum Reprod. 2001; 16: 1037–45.
   PubMed Web of Science ®Google Scholar
• Liu S, Kulp SK, Sugimoto Y., et al Involvement of breast epithe-lial-stromal interactions in the regulation of protein tyrosine phosphatase-gamma (PTPgamma) mRNA expression by estro-genically active agents. Breast Cancer Res Treat. 2002; 71: 21–35.
   PubMed Web of Science ®Google Scholar
• Liu S, Lin YC. Transformation of MCF-10A human breast epithelial cells by zeranol and estradio1-17B. Breast J. 2004; 10: 514–21.
   PubMedGoogle Scholar
• Davis S. Benzene: CEH marketing research report abstract. Chemical Industries Newsletter [Internet]. 2006 Sept. Avail-able from: www.sriconsulting.com/CEH/Public/Reports/ 452.0000/
   Google Scholar
• National Toxicology Program. Eleventh report on carcinogens. National Institute of Environmental Health Sciences. National Institutes of Health [Internet]. 2005. Available from: http://ntp.niehs.nih.gov/ntp.niehs.nih.gov/ntp/roc/elevent h/profiles/s019benz.pdf
   Google Scholar
• IARC.BenzeneJarc Monog Eval Carcinog Risk Chem Hum. 1987;Suppl 7: 120–2.
   Google Scholar
• Petralia SA, Chow W-H, McLaughlin J., et al Occupational risk factors for breast cancer among women in Shanghai. Am J Ind Med. 1998; 34: 477–83.
   PubMed Web of Science ®Google Scholar
• Rennix CP, Quinn MM, Amoroso PJ., et al Risk of breast cancer among enlisted Army women occupationally exposed to volatile organic compounds. Am J Ind Med. 2005; 48: 157–67.
   PubMed Web of Science ®Google Scholar
• Shaham J, Gurvich R, Coral A, Czernisk A. The risk of breast cancer in relation to health habits and occupational exposures. Am J Ind Med. 2006; 49: 1021–30.
   PubMed Web of Science ®Google Scholar
• Huff JE, Haseman JK, DeMarini DM., et al Multiple-site car-cinogenicity of benzene in Fisher 344 rats and B6C3F1 mice. Environ Health Persp. 1989; 82: 125–63.
   PubMed Web of Science ®Google Scholar
• Houle CD, Ton TV, Clayton N., et al Frequent p53 and H-ras mutations in benzene- and ethylene oxide-induced mammary gland carcinomas from B6C3F1 mice. Toxicol Pathol. 2006; 34: 752–62.
   PubMed Web of Science ®Google Scholar
• Labreche, FP, Goldberg, MS. Exposure to organic solvents and breast cancer in women: a hypothesis. Am J Ind Med. 1997; 32 (1): 1–14.
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency (EPA), Envirosense. Cleaning agents and cosmetics manufacturers [Internet]. 1996. Available from: es.epa.gov/techinfo/facts/cleaning.html.
   Google Scholar
• Wolff MS. Occupationally derived chemicals in breast milk. Am J Ind Med. 1983; 4: 259–81.
   PubMed Web of Science ®Google Scholar
• Chang YM, Tai CF, Lin RS., et al A proportionate cancer mor-bidity ratio study of workers exposed to chlorinated organic solvents in Taiwan. Industrial Health. 2003; 41: 77–87.
   PubMed Web of Science ®Google Scholar
• McElvenney DM, Darnton AJ, Hodson JT., et al Cancer among current and former workers at National Semiconductor (UK) LTD, Greenock: results of an investigation by the Health and Safety Executive. Norwich, UK Her Majesty's Stationary Office. 2001.
   Google Scholar
• Hansen J. Breast cancer risk among relatively young women employed in solvent-using industries. Am J Ind Med. 1999; 36: 43–7.
   PubMed Web of Science ®Google Scholar
• Cantor KP, Stewart, PA, Brinton LA, Dosemeci M. Occupa-tional exposures and female breast cancer mortality in the United States. J Occup Environ Med. 1995; 37 (3): 336–48.
   PubMed Web of Science ®Google Scholar
• Weiderpass E, Pukkala E, Kauppinen T., et al Breast cancer and occupational exposures in women in Finland. Am J Ind Med. 1999; 36: 48–53.
   PubMed Web of Science ®Google Scholar
• Wennborg H, Yuen J, Axelsson G., et al Mortality and cancer incidence in biomedical laboratory personnel in Sweden. Am J Ind Med. 1999; 35: 382–9.
   PubMed Web of Science ®Google Scholar
• Belli S, Comba P, De Santis M., et al Mortality study of workers employed by the Italian National Institute of Health, 1960-1989. Scand J Work Environ Health. 1992; 18: 64–7.
   PubMed Web of Science ®Google Scholar
• Walrath J, Li FP, Hoar SK., et al Causes of death among female chemists. Am J Public Health. 1985; 15: 883–5.
   Google Scholar
• Wang Fl, Kuo ML, Shun CT., et al Chronic toxicity of a mixture of chlorinated alkanes and alkenes in ICR mice. J Toxicol Env-iron Health, Part A. 2002; 65: 279–91.
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. Eleventh report on carcinogens. National Institute of Environmental Health Sciences. National Institutes of Health [Internet]. 2005. Available from: ntp-server.niehs.nih.gov ntp.niehs.nih.gov/ntp/roc/eleventh/pro-files/s186viny.pdf
   Google Scholar
• IARC (International Agency for Research on Cancer) 1987. Vinyl Chloride. IARC Summary & Evaluation, Suppl. 7. [Inter-net]. Available from:http://www.inchem.org/documents/ iarc/supp17/vinylchloride.html
   Google Scholar
• Chiazze L Jr., Ference LD. Mortality among PVC fabricating employees. Environ Health Persp. 1981; 41: 137–43.
   PubMed Web of Science ®Google Scholar
• Infante PF, Pesak J. A historical perspective of some occupa-tionally related diseases of women. J Occup Med. 1994; 36: 826–31.
   PubMedGoogle Scholar
• Agency for Toxic Substances and Disease Registry (ATSDR). Public health statement for vinyl chloride, CAS#75-01-4:. [Internet]. 1997. Available from: http://www.atsdr.cdc.gov/toxprofiles/phs20.html.
   Google Scholar
• U.S. Environmental Protection Agency. Health Assessment of 1,3-Butadiene. [Internet]. 2003. Available from: cfpub.epa. gov/ncea/cfm/ recordisplay.cfm?deid=54499
   Google Scholar
• National Toxicology Program. Eleventh report on carcinogens. National Institute of Environmental Health Sciences. National Institutes of Health [Internet]. 2005. Available from: ntp-server.niehs.nih.gov ntp.niehs.nih.gov/ntp/roc/eleventh/pro-files/ s025buta.pdf
   Google Scholar
• Melnick RL, Sills RC, Portier CJ., et al Multiple organ carcino-genicity of inhaled chloroprene (2-chloro-1,3- butadiene) in F344/N rats and B6C3F1 mice and comparison of dose-response with 1,3-butadiene in mice. Carcinogenesis. 1999; 20: 867–78.
   PubMed Web of Science ®Google Scholar
• National Toxicology Program (NTP), U.S. Department of Health and Human Services Toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (inhalation studies). NTP TR 434, NIH Pub. No. 93-3165. Research Triangle Park: NC. 1993.
   Google Scholar
• Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for ethylene oxide. U.S. Public Health Service, U.S. Department of Health and Human Services, Atlanta, GA. 1990.
   Google Scholar
• National Toxicology Program. Eleventh report on carcinogens. National Institute of Environmental Health Sciences. National Institutes of Health [Internet]. 2005. Available from: ntp-server.niehs.nih.gov ntp.niehs.nih.gov/ntp/roc/eleventh/pro files/ s085ethy.pdf
   Google Scholar
• Steenland K, Whelan E, Deddens J., et al Ethylene oxide and breast cancer incidence in a cohort study of 7,576 women. Cancer Causes Control. 2003; 14: 531–9.
   PubMed Web of Science ®Google Scholar
• Adam A, Bardo H, Adany R Increased genotoxic susceptibility of breast epithelial cells to ethylene oxide. Mut Res. 2005; 585: 120–6.
   PubMed Web of Science ®Google Scholar
• DeBruin LS, Pawliszyn JB, Josephy PD. Detection of mono-cyclic aromatic amines, possible mammary carcinogens, in human milk. Chem Res Toxicol. 1999; 12: 78–82.
   PubMed Web of Science ®Google Scholar
• DeBruin LS, Josephy PD. Perspectives on the chemical etiology of breast cancer. Environ Health Persp. 2002;110(Suppl 1):119–28.
   PubMedGoogle Scholar
• National Toxicology Program. Chemicals associated with site-specific tumor induction in mammary gland [Internet]. 2003. Available from: ntp-server.niehs.nih.gov/htdocs/sites/MAMM. html
   Google Scholar
• Layton DW, Bogen KT, Knize MG., et al Cancer risk of hetero-cyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis. 1995; 16: 39–52.
   PubMed Web of Science ®Google Scholar
• Steck SE, Gaudet MM, Eng SM., et al Cooked meat and risk of breast cancer: lifetime versus recent dietary intake. Epidemiol-ogy. 2007; 18: 373–82.
   PubMed Web of Science ®Google Scholar
• Thompson PA, DeMarini DM, Kadlubar FF., et al Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ Mol Mut. 2002; 39: 134–42.
   PubMed Web of Science ®Google Scholar
• Turesky RJ. Formation and biochemistry of carcinogenic hete-rocyclic aromatic amines in cooked meats. Toxicol Lett. 2007; 168: 219–27.
   PubMed Web of Science ®Google Scholar
• Gooderham NJ, Creton S, Lauber SN, Zhu H. Mechanisms of action of the carcinogenic heterocyclic amine PhIP. Toxicol Lett. 2006; 168: 269–77.
   PubMed Web of Science ®Google Scholar
• Environmental Protection Agency (EPA). Understanding radi-ation: gamma rays [Internet]. 2005. Available from: www.epa. gov/radiation/understand/gamma.htm
   Google Scholar
• National Toxicology Program. Eleventh report on carcinogens. National Institute of Environmental Health Sciences. National Institutes of Health [Internet]. 2005. Available from: ntp-server.niehs.nih.gov ntp.niehs.nih.gov/ntp/roc/eleventh/pro-files/s097zird.pdf
   Google Scholar
• Environmental Protection Agency. Federal radiation protec-tion guidance for exposure of the general public. Notice, Fed-eral Register December 23, 1994.
   Google Scholar
• Brenner DJ, Doll R, Goodhead DT., et al Cancer risks attribut-able to low doses of ionizing radiation. Proc Natl Acad Sci. 2003; 100 (24): 13761–6.
   PubMed Web of Science ®Google Scholar
• United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources and effects of ionizing radia-tion: UNSCEAR 1993 report to the General Assembly, with sci-entific annexes. 1993. p. 636.
   Google Scholar
• National Radiological Protection Board (Britain). Risk of radi-ation-induced cancer at low doses and low-dose rates for radia-tion protection purposes. Documents of the NRPB. 1995; 6 (1): 25.
   Google Scholar
• National Research Council. Biologic effects of ionizing radia-tion VII: Health risks from exposure to low levels of ionizing radiation. Washington DC: National Academy of Science. 2005.
   Google Scholar
• Goldberg Z, Lehnert BE. Radiation-induced effects in unirra-diated cells: a review and implications in cancer. Int J Oncol. 2003; 21: 337–49.
   Web of Science ®Google Scholar
• Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, castogenic factors and transgen-erational effects. Radiat Res. 2003; 159: 581–96.
   Google Scholar
• Wright EG. Radiation-induced genomic instability: manifesta-tions and mechanisms. Int J Low Radiat. 2004; 1: 231–41.
   Google Scholar
• Tsai KK, Chuang EY, Little JB, Yuan ZM. Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment. Cancer Res. 2005; 65: 6734–44.
   PubMed Web of Science ®Google Scholar
• Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment: tumorogenesis and therapy. Nat Rev Cancer. 2005; 5: 867–75.
   PubMed Web of Science ®Google Scholar
• Little JB. Genomic instability and radiation. J Radiolog Protect. 2003; 23: 173–81.
   PubMed Web of Science ®Google Scholar
• Murray D, MccEwan AJ. Radiobiology of systemic radiation therapy. Cancer Biother Radiopharm. 2007; 22: 1–22.
   PubMed Web of Science ®Google Scholar
• Turnbull C, Mirugaesu N, Eeles R. Radiotherapy and genetic predisposition to breast cancer. Clin Oncol. 2006; 18: 257–67.
   Web of Science ®Google Scholar
• Andrieu N, Easton DF, Chang-Claud J., et al Effect of chest X-rays on the risk of breast cancer among BRCA 1/2 mutation carriers in the International BRCA 1/2 Carrier Cohort Study: a report from EMBRACE, GEGNNEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol. 2006; 24: 3361–6.
   PubMed Web of Science ®Google Scholar
• Calaf GM, Hei TK. Establishment of a radiation- and estrogen-induced breast cancer model. Carcinogenesis. 2000; 21: 769–76.
   PubMed Web of Science ®Google Scholar
• Segaloff A, Maxfield WS. The synergism between radiation and estrogen in the production of mammary cancer in the rat. Cancer Res. 1971; 31: 166–8.
   PubMed Web of Science ®Google Scholar
• Segaloff A, Pettigrew HM. Effect of radiation dosage on the synergism between radiation and estrogen in the production of mammary cancer in the rat. Cancer Res. 1974; 38: 3445–52.
   Google Scholar
• Land CD. Radiation and breast cancer risk. Prog Clin Biol Res. 1997; 396: 115–24.
   PubMedGoogle Scholar
• Ron E, Ikeda T, Preston DL, Tokuoka S. Male breast cancer incidence among atomic bomb survivors. J Natl Cancer Inst. 2005; 97: 603–5.
   PubMed Web of Science ®Google Scholar
• Gofman JW. Preventing breast cancer: The story of a major, proven, preventable cause of this disease. 2nd ed. San Fran-cisco: CNR Book Division, Committee for Nuclear Responsibil-ity; 1996.
   Google Scholar
• MacKenzie I. Breast cancer following multiple fluoroscopies. Brit J Cancer. 196; 19: 1-8.
   Google Scholar
• Mattsson A, Ruden BI, Palmgren J, Rutqvist LE. Dose-and time-response for breast cancer risk after radiation therapy for benign breast disease. Brit J Cancer. 1995; 72: 1054–61.
   PubMed Web of Science ®Google Scholar
• Shore RE, Hildreth N, Woodard E., et al Breast neoplasms in women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst. 1986; 77: 689–96.
   PubMed Web of Science ®Google Scholar
• Lundell M, Mattsson A, Karlsson P., et al Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants. Radiat Res. 1999; 151: 626–32.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Robison LI, Oberlin O. et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996; 334: 745–51.
   PubMed Web of Science ®Google Scholar
• Travis LB, Hill DA, Dores GM., et al Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin's disease. J Am Med Assoc. 2003; 290: 465–75.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Yasui Y, Robison LL., et al High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol. 2003; 21: 4386–94.
   PubMed Web of Science ®Google Scholar
• Wahner-Roedler DL, Nelson DF, Croghan IT., et al Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin's lymphoma: Mayo Clinic experience. Mayo Clin Proc. 2003; 87: 708–15.
   Google Scholar
• van Leeuwen FE, Klokman WJ, Stovall M., et al Roles of radia-tion dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst. 2003; 95: 971–80.
   PubMed Web of Science ®Google Scholar
• Guibout C, Adjadj E, Rubino C., et al Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol. 2005; 23: 197–204.
   PubMed Web of Science ®Google Scholar
• Wahner-Roedler DL, Petersen IA. Risk of breast cancer and breast cancer characteristics in women after treatment for Hodgkin's lymphoma. Drugs Today. 2004; 40: 865–79.
   PubMed Web of Science ®Google Scholar
• Horwich A, Swerdlow AJ. Secondary primary breast cancer after Hodgkin's disease. Brit J Cancer. 2004; 90: 294–8.
   PubMed Web of Science ®Google Scholar
• El-Gamal H, Bennett RG. Increased breast cancer risk after radiotherapy for acne among women with skin cancer. J Am Acad Derm. 2006; 55: 981–9.
   PubMed Web of Science ®Google Scholar
• Morin-Doody M, Freedman DM, Alexande BH., et al Breast cancer incidence in U.S. radiologic technologists. Cancer. 2006; 106: 2707-15.
   Google Scholar
• Simon SL, Weinstock RM, Doody MM., et al Estimating histor-ical radiation doses to a cohort of U.S. radiologic technologists. Radiat Res. 2006; 166: 174–92.
   PubMed Web of Science ®Google Scholar
• Ballard T, Lagorio S, De Angelis G, Verdecchia A. Cancer inci-dence and mortality among flight personnel: a meta-analysis. Aviat Space Environ Med. 2000; 71: 216–24.
   PubMed Web of Science ®Google Scholar
• Gofman JW. Radiation from medical procedures in the patho-genesis of cancer and ischemic heart disease: Dose-response stud-ies with physicians per 100,000 population. San Francisco: CNR Book Division, Committee for Nuclear Responsibility; 1999.
   Google Scholar
• Bailar JC III. Mammography: a contrary view. Ann Intern Med. 1976; 84: 77–84.
   PubMed Web of Science ®Google Scholar
• Huda W, Nickoloff H1, Boone JM. Overview of patient dosime-try in diagnostic radiology in the USA for the past 50 years. Med. Physics 2008; 35: 5713-5728.
   Google Scholar
• National Cancer Institute. Radiation risks and pediatric com-puted tomography (CT): a guide for healthcare providers. [Internet]. 2002. Available from: www.cancer.gov
   Google Scholar
• Veronesi U, Luini A, Del Vecchio M., et al Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993; 328: 1587–91.
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials. Lancet. 2000; 355: 1757–70.
   Google Scholar
• Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Brit J Cancer. 2004; 91: 868–72.
   PubMed Web of Science ®Google Scholar
• Mellemkjaer L, Friis S, Olsen JH., et al Risk of second cancer among women with breast cancer. Int J Cancer. 2006; 118: 2285–92.
   PubMed Web of Science ®Google Scholar
• Huang J, Mackillop WJ. Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer. 2001; 92: 532–6.
   Google Scholar
• IARC. Non-Ionizing Radiation. IARC. Monog Eval Carcinog Risk Chem Hum. 2002; 80. Available at http://monographs. iarc.fr/ENG/Monographs/vol80/volume80.pdf
   Google Scholar
• NIEHS Working Group Report. Assessment of health effects from exposure to power-line frequency electric and magnetic fields. Research Park Triangle:National Institute of Environ-mental Health Sciences of the National Institutes of Health. 1998.
   Google Scholar
• BioInitiative Working Group. BioInitiative Report. 2007. Available at: http://www.bioinitiative.org/report/index.htm
   Google Scholar
• Erren TC. A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. Bio-electromagnetics. 2001;Suppl 5: S105-19.
   Google Scholar
• McElroy JA, Egan KM, Titus-Ernstoff L., et al Occupational exposure to electromagnetic field and breast cancer risk in a large, population-based, case-control study in the United States. J Occup Environ Med. 2007; 49: 266–74.
   PubMed Web of Science ®Google Scholar
• Peplonska B, Stewart P, Szeszenia-Dabrowska N., et al Occupa-tion and breast cancer risk in Polish women: a population-based case-control study. Am J Ind Med. 2007; 50: 97–111.
   PubMed Web of Science ®Google Scholar
• Kliukiene J, Tynes T, Anderson A. Follow-up of radio and tele-graph operators with exposure to electromagnetic fields and risk of breast cancer. Eur J Cancer Prey. 2003; 12: 301–7.
   PubMed Web of Science ®Google Scholar
• Dosemeci M, Blair A. Occupational cancer mortality among women employed in the telephone industry. J Occup Med. 1994;36;1204–9.
   PubMedGoogle Scholar
• Coogan PF, Clapp RW, Newcomb PA., et al Occupational expo-sure to 60-hertz magnetic fields and risk of breast cancer in women. Epidemiology. 1996; 7: 459–64.
   PubMed Web of Science ®Google Scholar
• Kliukiene J, Tynes T, Andersen A. Residential and occupational exposures to 50-Hz magnetic fields and breast cancer in women: a population-based study. Am J Epidemiol. 2004; 159: 852–61.
   PubMed Web of Science ®Google Scholar
• Feychting M, Forssen U, Rutqvist LE, Ahlbom A. Magnetic fields and breast cancer in Swedish adults residing near high-voltage power lines. Epidemiology. 1998; 9: 392–7.
   PubMed Web of Science ®Google Scholar
• Zhu K, Hunter S, Payne-Wilks K., et al Use of electric bedding devices and risk of breast cancer in African American women. Am J Epidemiol. 2003; 158: 798–806.
   PubMed Web of Science ®Google Scholar
• Milham S. A cluster of male breast cancer in office workers. Am J Ind Med. 2004; 46: 86–7.
   PubMed Web of Science ®Google Scholar
• Loomis DP. Cancer of breast among men in electrical occupa-tions (letter). Lancet. 1992; 339: 1482–3.
   PubMed Web of Science ®Google Scholar
• Tynes T, Andersen A, Langmark E Incidence of cancer in Nor-wegian workers potentially exposed to electromagnetic fields. Am J Epidemiol. 1992; 136: 81–8.
   PubMed Web of Science ®Google Scholar
• Matanoski GM, Breysse PN, Elliott EA. Electromagnetic field exposure and male breast cancer. Lancet. 1991; 337: 737.
   PubMed Web of Science ®Google Scholar
• Fedrowitz M, Kamino K, Loscher W. Significant differences in the effects of magnetic field exposure on 7,12-dimethyl-benz(a)anthracene-induced mammary carcinogenesis in two substrains of Sprague-Dawley rats. Cancer Res. 2004; 64: 243–51.
   PubMed Web of Science ®Google Scholar
• Stevens RG, Davis S, Thomas DB., et al Electric power, pineal function, and the risk of breast cancer. FASEB J. 1992; 6: 853–60.
   PubMed Web of Science ®Google Scholar
• Nie K, Henderson A. MAP kinase activation in cells exposed to a 60Hz electromagnetic field. J Cell Biochem. 2003; 90: 1197-1206.
   Google Scholar
• Sanchez-Barcelo EJ, Cos S, Mediavilla D., et al Melatonin-estro-gen interactions in breast cancer. J Pineal Res. 2005; 38: 217–22.
   PubMed Web of Science ®Google Scholar
• Blask DE, Wilson ST, Zalatan F. Physiological melatonin inhibi-tion of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway. Cancer Res. 1997; 57: 1909–14.
   PubMed Web of Science ®Google Scholar
• Hensen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology. 2001; 12: 74–7.
   PubMed Web of Science ®Google Scholar
• Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001; 93: 1557–62.
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Laden F, Speizer FE., et al Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 2001; 93: 1563–8.
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005; 97: 1084–7.
   PubMedGoogle Scholar
• Schernhammer ES, Berrino F, Krogh V., et al Urinary 6-sul-foxymelatonin levels and risk of breast cancer in post-menopausal women. J Natl Cancer Inst. 2008; 100: 898–105.
   PubMed Web of Science ®Google Scholar
• Nudelman J, Taylor B, Evans N., et al Policy and research rec-ommendations emerging from the scientific evidence connect-ing environmental factors and breast cancer. Int J Occup Envi-ron Health. 2008.
   Google Scholar